Emerging evidence has shown that pro-inflammatory cytokines, such as interleukin (IL)-6 and IL-8, are particularly promising as serum biomarkers for PSCID, as their levels show a positive trend among those experiencing cognitive decline (Rafnsson et al., 2007 ; Rani et al., 2022 ; Weaver et al., 2002 ).
← all excerpts
Linking evidence for targeted blood biomarkers in post-stroke cognitive impairment and dementia.
1
—
—